Authors
Table of contents
In this article discover…
For life sciences, pharmaceutical and biotech organisations, operations are centred around innovation. In these industries, R&D tax relief plays an important role in helping recover costs from projects and reinvest in future development. In-house R&D claim management is common in larger businesses where R&D spans development programmes, clinical trials, digital health, advanced therapeutics and more. However, for many managing claims internally, processes are manual, systems are outdated, and administrative burden becomes significant.
Capturing qualifying R&D activity accurately across teams is incredibly complex, and when paired with outdated systems and manual data processes, companies face risks when claiming relief. With increased scrutiny from HMRC around documentation quality and evidential support, the need for stronger claim governance is vital.
Why R&D tax claims are particularly complex in life sciences
Long development timelines create documentation challenges
Innovation in life sciences rarely follows short project cycles. Drug discovery alone can take several years, with pre-clinical testing adding further time before formal clinical trials even begin. Full development programmes may run for a decade or more. This creates a practical challenge for in-house claim management:
how do you accurately evidence qualifying R&D when projects span multiple years, evolving teams and changing technical objectives?
Retrospective claim preparation often leads to incomplete records, missing technical rationale and fragmented supporting evidence.
R&D activity spans multiple specialist teams
Qualifying innovation in life sciences extends beyond laboratory research. Depending on the organisation, eligible activity may involve:
- Scientists and researchers
- Clinical teams
- Manufacturing and process development teams
- Software and modelling specialists
- Data science teams
- Engineering functions
- Regulatory teams supporting technical uncertainty resolution
This makes identifying qualifying activity significantly more complex than in more contained innovation environments. Different teams often document work in entirely different ways, if at all, making consistency difficult.
Regulatory requirements increase evidential complexity
Life sciences innovation operates within highly regulated environments. Beyond product feasibility, the industry faces additional obstacles in stability testing, formulation work, packaging validation, manufacturing scalability and safety protocols. For R&D tax purposes, distinguishing qualifying technical uncertainty from commercial or regulatory processes requires clear documentation and robust evidencing.
Knowledge loss creates compliance risk
Long-running R&D programmes face institutional knowledge loss. Staff turnover, restructuring, mergers or project ownership changes can result in critical technical context disappearing over time. If claim preparation relies on retrospective interviews or fragmented spreadsheets, valuable evidence may no longer be recoverable, and claims may be undervalued or inaccurate.
Why spreadsheets are no longer enough for in-house R&D tax governance
Many organisations still rely on spreadsheets, disconnected finance systems and manual evidence gathering to manage claims internally. While this may be manageable for smaller claims, it becomes increasingly inefficient as project volume and complexity grow. Common challenges include:
- inconsistent project documentation
- duplicated efforts and limited visibility across teams
- poor evidencing and technical narratives
- reliance on individual knowledge holders
- difficulty forecasting R&D tax benefit and planning future projects
Building a stronger internal R&D tax governance framework
Align finance, tax and technical teams
Improving claim efficiency starts with a process re-design. One of the most effective ways to do this is to create stronger collaboration between finance, tax and technical stakeholders. Each function holds part of the picture:
- technical teams understand the scientific or engineering uncertainty
- finance teams control cost capture and forecasting
- tax teams interpret eligibility and compliance requirements
Without alignment, qualifying activity can easily be missed or incorrectly categorised. Regular internal workshops, shared definitions and agreed documentation standards help create consistency.
Embed R&D documentation into project workflows
Capturing evidence in real time is significantly more effective than reconstructing projects retrospectively. This means integrating R&D documentation into existing delivery workflows rather than treating claim preparation as a year-end exercise. This approach improves both efficiency and evidential quality.
Standardise qualification criteria
In fast-moving innovation environments, teams may interpret R&D differently. This becomes even more relevant across software development, cloud computing, data-intensive tests, or outsourced activities. Clear internal guidance helps ensure consistent decision-making and reduces downstream rework.
Using digital tools to streamline in-house R&D claim management
For larger organisations, incorporating a centralised digital tool can create the governance structure needed for efficient in-house claim management. Our own Ayming Advance is designed specifically to support R&D tax claim management by helping organisations centralise documentation, improve visibility and standardise workflows. Key benefits include:
- Centralised claim data: A single source of truth reduces fragmentation across spreadsheets, email chains and disconnected teams.
- Workflow automation: Automated data uploads, contract reviews and transparent workflows help ensure documentation is efficient and streamlined.
- Real-time visibility: Finance and tax teams gain clearer oversight of qualifying activity and expenditure throughout the year, supporting more accurate forecasting and faster claim preparation.
- Better knowledge retention: Where projects span multiple years or team structures change, a centralised source of up-to-date data reduces reliance on individual knowledge holders.
- Controlled governance: Permission-based access helps ensure sensitive technical and financial data is appropriately managed while maintaining cross-functional collaboration.
Future-proofing R&D tax claims in life sciences
As R&D tax compliance expectations continue to evolve, governance will become an increasingly important differentiator between efficient claims and resource-heavy processes.
By combining stronger internal processes, clearer cross-functional collaboration and fit-for-purpose digital tools, organisations can improve efficiency, strengthen compliance and create a more resilient approach to in-house R&D tax management.
Discover more about Ayming’s own digital claim management tool, Ayming Advance.
